{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Kardiovaskul\u00E1rn\u00ED syst\u00E9m" , "@language" : "cs" } ,        { "@value" : "CARDIOVASCULAR SYSTEM" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM" , "@language" : "en" } ,        { "@value" : "L\u00E9\u010Diva ovliv\u0148uj\u00EDc\u00ED renin-angiotenzinov\u00FD syst\u00E9m" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ACE INHIBITORS, PLAIN" , "@language" : "en" } ,        { "@value" : "ACE inhibitory, samotn\u00E9" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09AA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ACE inhibitors, plain" , "@language" : "en" } ,        { "@value" : "ACE inhibitory, samotn\u00E9" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09AA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C09AA05",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/C" ,        "http://linked.opendata.cz/resource/ATC/C09" ,        "http://linked.opendata.cz/resource/ATC/C09A" ,        "http://linked.opendata.cz/resource/ATC/C09AA" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Ramipril" , "@language" : "cs" } ,        { "@value" : "Ramipril" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C09AA05" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypotension" , "@language" : "en" } ,        { "@value" : "Hypotenze" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001573",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hyperaldosteronism" , "@language" : "en" } ,        { "@value" : "Hyperaldosteronismus" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000415",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Angioedema" , "@language" : "en" } ,        { "@value" : "Angioed\u00E9m" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026184",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Ramipril" , "@language" : "en" } ,        { "@value" : "Ramipril" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000415" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001573" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/MEDORAM-2-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026184" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131734" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131733" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131738" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131736" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131737" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131735" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131742" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131741" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131740" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131739" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131743" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Inhibitory angiotenzin konvertuj\u00EDc\u00EDho enzymu" , "@language" : "cs" } ,        { "@value" : "Angiotensin-converting enzyme inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antihypertensive agents" , "@language" : "en" } ,        { "@value" : "Antihypertenz\u00EDva" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131743",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "500" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 500X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131742",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 100X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131741",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 100X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131740",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "98" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 98X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131739",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 50X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131738",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "42" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 42X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131736",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "28" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 28X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131737",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2010-02-01" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 110.2900009155273 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 75.86000061035156 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131735",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 20X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131734",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "14" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 14X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0131733",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORAM 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C09AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HYPOTENSIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC119419_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba hypertenze\nKardiovaskul\u00E1rn\u00ED prevence: sn\u00ED\u017Een\u00ED kardiovaskul\u00E1rn\u00ED morbidity a mortality u pacient\u016F:\ns manifestn\u00EDm aterotrombotick\u00FDm kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm (anamn\u00E9za onemocn\u011Bn\u00ED koron\u00E1rn\u00EDch tepen nebo mozkov\u00E9 p\u0159\u00EDhody, nebo onemocn\u011Bn\u00ED perifern\u00EDch c\u00E9v) nebo\ns diabetem a s nejm\u00E9n\u011B jedn\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1).\nL\u00E9\u010Dba onemocn\u011Bn\u00ED ledvin:\no incipientn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definovan\u00E1 p\u0159\u00EDtomnost\u00ED mikroalbuminurie\no manifestn\u00ED glomerul\u00E1rn\u00ED diabetick\u00E1 nefropatie definov\u00E1na makroproteinuri\u00ED u pacient\u016F s nejm\u00E9n\u011B jedn\u00EDm dal\u0161\u00EDm kardiovaskul\u00E1rn\u00EDm rizikov\u00FDm faktorem (viz bod 5.1)\no manifestn\u00ED glomerul\u00E1rn\u00ED nediabetick\u00E1 nefropatie definovan\u00E1 makroproteinuri\u00ED \u2265 3 g/den (viz bod 5.1).\nL\u00E9\u010Dba symptomatick\u00E9ho selh\u00E1n\u00ED srdce\nSekund\u00E1rn\u00ED prevence po akutn\u00EDm infarktu myokardu: sn\u00ED\u017Een\u00ED mortality v akutn\u00ED f\u00E1zi infarktu myokardu u pacient\u016F s klinick\u00FDmi p\u0159\u00EDznaky selh\u00E1n\u00ED srdce, se za\u010D\u00E1tkem l\u00E9\u010Dby > 48 hod po akutn\u00EDm infarktu myokardu\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 10X2.5MG" , "@language" : "cs" } ] }] }